This event has ended. Visit the official site or create your own event on Sched.

View analytic
Tuesday, June 28 • 8:00am - 9:30am
#202: Changing Cultures to Advance Patient Engagement

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Component Type: Forum
Level: Intermediate
CE: ACPE 1.50 Knowledge UAN: 0286-0000-16-614-L04-P; CME 1.50; IACET 1.50; RN 1.50

The importance of engaging patients in medical product development is a message that has reached the industry. Acting on that message to adopt and sustain meaningful practice requires organizational cultures that value and place high priority on patient focus. In this session, sponsor companies and patient organizations will share their experiences with building internal cultures that encourage the collective group and individuals to incorporate patient engagement into their everyday work. A diverse panel will discuss reframing the challenges of cultural change to achieve the best outcomes for patients in the health care process.

Learning Objectives

Explain the role of organizational culture in enabling meaningful patient engagement practices; Assess key motivators for organizations to adopt a patient-focused culture; Describe effective approaches to incorporating patient focus throughout the organization; Discuss ways to meet challenges that may prevent a fully patient-focused culture.


Kim McCleary


Lode Dewulf

Andrea Stern Ferris

Andrew J. Garvey

Mary Stober Murray, MBA

Durhane Wong-Rieger, PhD, MA

avatar for Kim McCleary

Kim McCleary

Managing Director, Fastercures
Kim McCleary is Managing Director of FasterCures, a center of the Milken Institute. She leads a new FasterCures program to advance the science of patient input and expand patient engagement in FDA’s assessment of benefits and risks for medical products. She has participated in every opportunity organized by the FDA to shape its Patient-Focused Drug Development Initiative (PFDDI) and has worked with several patient organizations to prepare for... Read More →

avatar for Lode Dewulf

Lode Dewulf

Vice President and Chief Patient Affairs Officer, UCB
Lode Dewulf has a passion for patient perspectives and understanding. As medical practitioner he deeply realized that good health education was at least as important as good medicines. in 1989 he joined the pharmaceutical industry, to provide good education on diseases and new treatments. In 1999 he took a 1y sabbatical to co-found PlanetMedica, Europe’s first Healthcare internet portal. With now >25y of global pharmaceutical experience he... Read More →
avatar for Andrea Ferris

Andrea Ferris

President and Chairman, LUNGevity Foundation
Andrea is the President and Chairman of LUNGevity. In her role as President of LUNGevity, Andrea is responsible for setting and executing the strategic direction of the organization and its science programs. Prior to LUNGevity, Andrea had a variety of management experiences. She worked at Decision Lens, a software company she helped launch, Johnson& Johnson, Lehman Brothers and Coopers & Lybrand. Andrea received her MBA from Wharton with... Read More →
avatar for Andrew Garvey

Andrew Garvey

Global Patient Advocacy Lead, GlaxoSmithKline
Andrew leads GSK’s global work with patient organizations (excluding the US). He is responsible for leading the work to develop collaborations with patient organizations to bring patient insight into GSK, improve the management of diseases and to strengthen the capabilities of patient organizations. Andrew has worked at GSK for 20 years in sales and marketing, public affairs and communications roles before leading on first GSK’s patient... Read More →
avatar for Mary Murray

Mary Murray

Associate Director, Diversity and Patient Engagement, Bristol-Myers Squibb Company
Mary Stober Murray is responsible for supporting global clinical development efforts by building relationships with advocacy organizations and diverse patient and provider communities to keep them informed, educated and prepared to support clinical development of BMS compounds.
avatar for Durhane Wong-Rieger

Durhane Wong-Rieger

President and Chief Executive Officer, Canadian Organization For Rare Disorders (CORD)
Durhane Wong-Rieger, PhD, is President, Institute for Optimizing Health Outcomes; President; Canadian Organization for Rare Disorders; Chair, Consumer Advocare Network; Past-Chair, International Alliance of Patient Organizations; Co-Chair, HTAi Patient / Citizen Involvement IG; Board, DIA International; Advisory Board, Canadian Institutes of Health Research Institute of Genetics. Durhane has a PhD in psychology from McGill and was professor at... Read More →

Tuesday June 28, 2016 8:00am - 9:30am
103ABC Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA